| Eos Announces $125 Million Investment for Frontier Power USA, Bringing Expected Frontier Equity Investment up to $375 Million |
Globe Newswire |
06/30 |
07:55 |
| Eos Energy Announces Updated Terms for Rights Offering |
Globe Newswire |
06/30 |
07:50 |
| ZenaTech Reports Annualized Revenue Run Rate of Approximately CAD $33 Million Based on First Quarter 2026 Revenue |
Globe Newswire |
06/30 |
07:45 |
| Eos Announces Pricing of Registered Direct Offering of Common Stock and Warrants to Fund Investment in Frontier Power USA |
Globe Newswire |
06/30 |
07:45 |
| One Bullion Announces Board Transition |
Globe Newswire |
06/30 |
07:30 |
| Palvella Therapeutics Appoints Accomplished Rare Disease Biotech Executive and Commercial Leader Matt Pauls, J.D., M.B.A., to Board of Directors |
Globe Newswire |
06/30 |
07:30 |
| FocalTherics™ Announces Successful Launch of First Commercial Endometriosis Focal One® Program in Europe with Treatment of Initial Patients |
Globe Newswire |
06/30 |
07:30 |
| Blockfusion and Blue Acquisition Corp. Announce LOIs for Anchor Lease with a Leading AI Customer and $175 Million Convertible Note Financing and Non-Redemption Agreement, and Advancement of Planned Expansion of Niagara Falls Campus |
Globe Newswire |
06/30 |
07:30 |
| OptimizeRx Launches CopayCue™, a Next-Generation Copay Activation Solution Powered by Real-Time Prescribing Intent |
Globe Newswire |
06/30 |
07:30 |
| Plus Therapeutics Provides Mid-Year Business Update Including Corporate Rebranding |
Globe Newswire |
06/30 |
07:30 |
| Pacira BioSciences Announces Agreement to Divest its iovera° Business to Zimmer Biomet |
Globe Newswire |
06/30 |
07:30 |
| Pyxis Oncology Announces Up to $114 Million Private Placement Financing to Advance MICVO Through Key Clinical Milestones |
Globe Newswire |
06/30 |
07:30 |
| Edible Garden Announces Letter of Intent for Strategic Commercialization Alliance |
Globe Newswire |
06/30 |
07:27 |
| BingX Partners with Save the Children to Support Children at Risk in Western Balkans |
Globe Newswire |
06/30 |
07:12 |
| Bilibili Inc. Provides Update on Share Repurchase Program |
Globe Newswire |
06/30 |
07:10 |
| Unicycive Therapeutics Receives Complete Response Letter from FDA Regarding Resubmitted Oxylanthanum Carbonate (OLC) New Drug Application (NDA) |
Globe Newswire |
06/30 |
07:05 |
| Corten Capital and Ampersand Capital Partners Complete Acquisition of Beacon Intelligence to Accelerate Growth in Life Sciences R&D Intelligence |
Globe Newswire |
06/30 |
07:00 |
| Generative Engine Optimization Is Reshaping B2B Discovery |
Globe Newswire |
06/30 |
07:00 |
| Auddia Launches Discovr Radio Monthly Subscription Model, Advancing Shift Toward Recurring Revenue |
Globe Newswire |
06/30 |
07:00 |
| RUM Group Inc. Announces the Filing of Updated Investor Materials |
Globe Newswire |
06/30 |
07:00 |
| Pasithea Therapeutics Announces Positive Interim Phase 1 Advanced Cancer Study Data Demonstrating Long-Term Safety and Tolerability, and Durable Clinical Activity in MEK/BRAF-Pretreated Patients, plus Protocol Expansion |
Globe Newswire |
06/30 |
07:00 |
| Solana Company Partners with Alatau City to Advance Digital Asset Infrastructure and Blockchain Adoption in Central Asia |
Globe Newswire |
06/30 |
07:00 |
| Aurora Mobile’s JPush Partners with CICC Wealth Management to Enhance the Digital Wealth Management Experience |
Globe Newswire |
06/30 |
07:00 |
| Blossom Gold Reports Initial, Open Pit Expansion and Infill Drill Results from the Rosebud Open-Pit, Heap-Leach Project |
Globe Newswire |
06/30 |
07:00 |
| AC Immune Reports Interim 12-Month Data from Phase 1b/2 ABATE Trial of ACI-24 in Prodromal Alzheimer’s Disease |
Globe Newswire |
06/30 |
07:00 |
